Litcius/Paper detail

Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies

Rémy Duléry, Claire Goudet, Daniele Mannina, Antonio Bianchessi, Angéla Granata, Samia Harbi, Valério Maisano, Christian Chabannon, Florent Malard, Éolia Brissot, Simona Sestili, Anne Banet, Zoé Van de Wyngaert, Ramdane Belhocine, Stéphane Éderhy, Luca Castagna, Stéfania Bramanti, Didier Blaise, Mohamad Mohty, Sabine Fürst, Raynier Devillier

2022Bone Marrow Transplantation65 citationsDOI

Topics & Concepts

MedicineHemorrhagic cystitisInternal medicineCyclophosphamideGastroenterologyHematopoietic stem cell transplantationTransplantationGraft-versus-host diseaseSurgeryChemotherapyHematopoietic Stem Cell TransplantationPolyomavirus and related diseasesImmune Cell Function and Interaction
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies | Litcius